Diphtheria tetanus pertussis hepatitis b poliomyelitis vaccine
Infanrix Penta
This page is kept for reference and is not offered to search engines.
Indication
Infanrix Penta is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B and poliomyelitis.
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Source: European Medicines Agency, EPAR list (imported 10 June 2026).
Licence: EMA content, reuse with acknowledgement · Added 10 Jun 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Diphtheria tetanus pertussis hepatitis b poliomyelitis vaccine
- Register
- European Union (EMA)
- Status
- Cancelled
- Status in the register
- Lapsed
- Authorised
- 23 Oct 2000
- Registration
- EMEA/H/C/000295
- Marketing authorisation holder
- GlaxoSmithKline Biologicals S.A.
- ATC code
- J07CA12
- Therapeutic area
- Hepatitis B;Tetanus;Immunization;Whooping Cough;Poliomyelitis;Diphtheria
- Procedure
- EU centralised
- EMA product number
- EMEA/H/C/000295